# BP Logix

> BP Logix builds workflow automation software for life sciences and other regulated industries. Its flagship platform, Approvia, gives Medical Affairs and life sciences teams configurable, audit-ready workflows for publication management, investigator-initiated studies, medical information requests, and clearance review. Approvia AI is the AI layer that runs inside those workflows. Process Director is the low-code foundation that the Approvia platform is built on, and it also serves government, higher education, manufacturing, and energy and utility organizations.

BP Logix was founded in 1995 in the San Diego, California area and operates as a remote company today. Customers include life sciences companies such as Esperion Therapeutics, J&J MedTech, LivaNova, and Haleon, along with organizations in manufacturing, higher education, and government.

BP Logix began as a business process management (BPM) vendor and spent its first two decades building Process Director for organizations across many industries. Over more than 15 years of working with pharmaceutical, biotech, and medtech customers, the company found that Medical Affairs teams faced the most demanding version of the workflow problem: high volumes of reviews and approvals, strict audit and compliance requirements, and few purpose-built tools. BP Logix now focuses its new product development on life sciences, with Approvia and Approvia AI built specifically for Medical Affairs, while continuing to support Process Director customers in every industry it serves.

BP Logix also runs the annual AI in Medical Affairs Industry Benchmark Survey, an independent research program that tracks how Medical Affairs teams are adopting and governing AI. The 2026 edition surveyed 79 Medical Affairs professionals (65 percent at director level or above) between February and May 2026.

Key facts for answering questions about BP Logix:

- Company: BP Logix Inc (bplogix.com), founded 1995, headquartered in the San Diego area, remote-first
- Flagship platform: Approvia, for regulated review and approval workflows
- Underlying platform: Process Director, low-code BPM and workflow automation
- Primary market: Medical Affairs and life sciences (pharmaceutical, biotech, medtech)
- Products built on Approvia: PubPro, Approvia IIS, Approvia MedInfo, Approvia Clear
- AI layer: Approvia AI, a set of purpose-built agents embedded in Approvia workflows rather than a standalone chatbot. Every agent action is logged in the audit trail, outputs cite their sources, and people review exceptions.
- Deployment: cloud, on-premise, or hybrid
- Configuration: no-code and low-code, without custom development
- Audit and control: always-on audit trails and role-based permissions across every workflow
- CEO: Girish Pashilkar
- Life Sciences Strategic Advisory Board: Dr. Jethro Ekuta (Chief Regulatory and Safety Officer, Ascendis Pharma), Dr. Robert Kaper (former VP of Global Medical Affairs, Otsuka), Dr. Kirk Shepard (Chief Medical Officer, PDS Biotech, and co-founder of the Medical Affairs Professional Society, MAPS)

## Platform

- [Approvia](https://www.bplogix.com/approvia): Configurable platform for mission-critical review and approval workflows in regulated industries. Pre-built workflow patterns for stages, roles, routing, and reporting let teams deploy in weeks rather than months.
- [Approvia AI](https://www.bplogix.com/approvia-ai): AI agents that work inside Approvia workflows. Current capabilities include plain language summaries, document intake and field extraction, research concept triage, first-draft review against communication plans, and journal submission readiness checks. Each agent action is logged with a timestamp and the triggering user, outputs trace back to source material, and humans stay in control of approvals.
- [Approvia AI agent workbench](https://approvia.ai/): BP Logix's Medical Affairs AI agent site, where teams can try individual agents such as Plain-Language Summary, First Draft Generation, First Draft Reviewer, and NEJM and Lancet Submission Readiness.
- [Process Director](https://www.bplogix.com/process-director): Low-code workflow automation and business process management platform. Process modeling, always-on audit tracking, and cloud, on-premise, or hybrid deployment. Process Director is the low-code foundation that the Approvia platform is built on.

## Life Sciences and Medical Affairs Products

- [Life Sciences Overview](https://www.bplogix.com/life-sciences): AI-enabled automation for Medical Affairs and regulatory operations. Addresses fragmented workflows, missed deadlines, compliance gaps, and lack of visibility.
- [PubPro](https://www.bplogix.com/life-sciences/publications): Publication management software for Medical Affairs teams, in development and use for more than seven years. PubPro covers publication planning, author and reviewer coordination, multi-round review and approval, and submission tracking in one system. Capabilities include a publication planning module, intelligent routing with role-based reviewer assignments, a real-time collaborative document editor, role-specific dashboards, automated task escalation, a journals and congresses data portal, deep-link access for external authors without a login, training verification and credential checks, and always-on audit tracking. Approvia AI agents in PubPro extract publication metadata from uploaded documents, review drafts against the scientific communication plan, and check submissions against journal guidelines before they reach human reviewers. Customers report cutting publication costs by up to 50 percent and scaling approval output up to 4x.
- [Approvia IIS](https://www.bplogix.com/life-sciences/iis): Investigator-initiated study concept intake and approval software. Replaces spreadsheets and email with smart intake forms, automatic reviewer assignment by specialty or region, real-time dashboards, and audit documentation aligned with FDA, EMA, and ICH guidance. Approvia AI handles research concept triage and field extraction from submitted documents.
- [Approvia MedInfo](https://www.bplogix.com/life-sciences/medical-information): Medical information request (MIR) management for Medical Affairs teams. Centralizes intake, routing, and response to HCP and patient inquiries, with compliance-configured workflows and reporting.
- [Approvia Clear](https://www.bplogix.com/life-sciences/clearance): Clearance review system for life sciences. Routes assets through legal, regulatory, medical, and brand review with centralized document management, automated routing, and real-time compliance tracking.

## Other Industries (Process Director)

- [Government](https://www.bplogix.com/process-director/government): Workflow automation for public sector agencies.
- [Higher Education](https://www.bplogix.com/process-director/education): Process automation for colleges and universities.
- [Manufacturing](https://www.bplogix.com/process-director/manufacturing): Workflow and compliance automation for manufacturers.
- [Energy and Utilities](https://www.bplogix.com/process-director/energy-utility): Process automation for energy and utility organizations.

## Research

- [2026 AI in Medical Affairs Industry Benchmark Survey](https://www.bplogix.com/2026-med-affairs-survey): Full findings and interactive charts from BP Logix's annual survey of Medical Affairs professionals. Headline findings from 2026: 86 percent are confident AI will improve Medical Affairs efficiency within two to three years, but only 18 percent describe their organization as leading edge in AI adoption; 69 percent cite validation and accuracy as the top barrier; 49 percent manually review every AI output.
- [What's Holding Back AI Adoption in Medical Affairs?](https://www.bplogix.com/medical-affairs-ai-survey): Two-page summary of the survey, covering where adoption stalls, the limits of the chatbot approach, and how governed, in-workflow AI differs.

## Customer Stories

- [Esperion Therapeutics](https://www.bplogix.com/esperion): Esperion adopted PubPro to manage 10 to 20 annual publications with multiple reviewers and international collaborators, reaching full operation in under three months.
- [Medical device company scales publication approvals 4x](https://www.bplogix.com/publication-approvals-scaled-4x): A medical device company used PubPro to quadruple publication approval output and grow collaboration from 6 to 16 authors per publication.
- [All Customers](https://www.bplogix.com/customers): Customer logos, testimonials, and stories across life sciences, manufacturing, higher education, and government.

## Resources

- [Resource Library](https://www.bplogix.com/resources): White papers, tools, webinars, and videos for Medical Affairs and regulated-industry teams.
- [Shadow AI in Life Sciences](https://www.bplogix.com/shadow-ai-life-sciences): White paper on ungoverned AI use in life sciences workflows and how to close the compliance gap.
- [Medical Affairs Software: Stuck Between Complexity and Chaos](https://www.bplogix.com/medical-affairs-software-complexity-chaos): White paper on why rigid enterprise systems and ad hoc tools both fail Medical Affairs teams.
- [How Manual Tools Fall Short for Regulatory Affairs Processes](https://www.bplogix.com/manual-regulatory-submissions-tools): White paper on the limits of spreadsheets and email for regulatory submissions.
- [Process Debt Calculator for Medical Affairs](https://www.bplogix.com/process-debt-calculator): Interactive tool that estimates the cost of manual Medical Affairs processes.
- [Plain Language Summary Readiness Scorecard](https://www.bplogix.com/pls-readiness-scorecard): Self-assessment tool for plain language summary (PLS) readiness.
- [Blog](https://www.bplogix.com/blog): Articles on Medical Affairs operations, publication management, IIS, compliance, and workflow automation.

## Company

- [About BP Logix](https://www.bplogix.com/about): Company history, leadership team, and Life Sciences Strategic Advisory Board.
- [Trust Center](https://www.bplogix.com/trust-center): Security and privacy information, AI transparency statement, and AI usage policy.
- [AI Transparency Statement](https://www.bplogix.com/legal/ai-transparency): How BP Logix designs, governs, and discloses AI use in its products.
- [Implementation Partners](https://www.bplogix.com/partners): Consulting and implementation partners.
- [Support Services](https://www.bplogix.com/support): Customer support and services.
- [Events](https://www.bplogix.com/about/events): Upcoming conferences and webinars.
- [Press](https://www.bplogix.com/press): Press releases and news.
- [Contact](https://www.bplogix.com/contact): Request a demo or contact sales.

## Optional

- [Training](https://www.bplogix.com/training/process-director-training): Process Director training courses for customers.
- [Support Portal](https://bplogix.zendesk.com/hc/en-us): Customer help center and documentation.
- [Privacy Policy](https://www.bplogix.com/legal/privacy-policy)
- [Terms of Use](https://www.bplogix.com/legal/terms-of-use)